We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Sector Composition

Rank Sector Weight
1 Technology 26.99%
2 Healthcare 10.86%
3 Consumer Discretionary 10.71%
4 Financials 8.62%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MPV
6326
Barings Participation Investors
MPV
$176M
-592
Closed -$7K
MRCC
6327
DELISTED
Monroe Capital Corp
MRCC
-1,177
Closed -$11K
MRKR icon
6328
Marker Therapeutics
MRKR
$19.2M
-2,231
Closed -$8.19K
MSC
6329
Studio City International Holdings
MSC
$341M
$0 ﹤0.01%
+10
New +$19
MVF
6330
DELISTED
BlackRock MuniVest Fund
MVF
-378
Closed -$3K
MXI icon
6331
iShares Global Materials ETF
MXI
$363M
$0 ﹤0.01%
+6
New +$442
MYPSW
6332
DELISTED
PLAYSTUDIOS Inc Warrant
MYPSW
$0 ﹤0.01%
44
NAK
6333
Northern Dynasty Minerals
NAK
$953M
-2,612
Closed -$1K
NCTY
6334
The9 Ltd
NCTY
$69.2M
$0 ﹤0.01%
9
-410
-98% -$5.85K
NCV
6335
Virtus Convertible & Income Fund
NCV
$391M
$0 ﹤0.01%
+3
New +$45
NERV icon
6336
Minerva Neurosciences
NERV
$215M
-3,995
Closed -$13K
NEXA icon
6337
Nexa Resources
NEXA
$1.97B
$0 ﹤0.01%
85
-32
-27% -$185
NEXN
6338
Nexxen International
NEXN
$599M
-25
Closed
NGL icon
6339
NGL Energy Partners
NGL
$2.14B
$0 ﹤0.01%
206
NKSH icon
6340
National Bankshares
NKSH
$257M
-149
Closed -$5K
NNVC icon
6341
NanoViricides
NNVC
$35.7M
-2,251
Closed -$4K
NRGU icon
6342
MicroSectors U.S. Big Oil 3x Leveraged ETNs due Feb 17 2045
NRGU
$22.3M
-411
Closed -$134K
NRIM icon
6343
Northrim BanCorp
NRIM
$588M
-11,832
Closed -$119K
NRO
6344
Neuberger Real Estate Securities Income Fund Inc
NRO
$189M
$0 ﹤0.01%
+105
New +$408
NRP icon
6345
Natural Resource Partners
NRP
$1.39B
-57
Closed -$2K
NRSN icon
6346
NeuroSense Therapeutics
NRSN
$17.5M
-9,794
Closed -$33K
NRT
6347
North European Oil Royalty Trust
NRT
$83.5M
-22
Closed
NRXPW
6348
DELISTED
NRX Pharmaceuticals Warrant
NRXPW
$0 ﹤0.01%
15
NSPR icon
6349
InspireMD
NSPR
$37.5M
-96
Closed
NSTS icon
6350
NSTS Bancorp
NSTS
$66.7M
-93
Closed -$1K

Similar funds

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.